BRPI0717223A2 - polipeptÍdeos hÍbridos imunogÊnicos antiobesidade e composiÇço de vacina antiobesidade compreendendo os mesmos - Google Patents

polipeptÍdeos hÍbridos imunogÊnicos antiobesidade e composiÇço de vacina antiobesidade compreendendo os mesmos

Info

Publication number
BRPI0717223A2
BRPI0717223A2 BRPI0717223-0A2A BRPI0717223A BRPI0717223A2 BR PI0717223 A2 BRPI0717223 A2 BR PI0717223A2 BR PI0717223 A BRPI0717223 A BR PI0717223A BR PI0717223 A2 BRPI0717223 A2 BR PI0717223A2
Authority
BR
Brazil
Prior art keywords
obesity
same
vaccine composition
immunogenic polypeptides
hybrid immunogenic
Prior art date
Application number
BRPI0717223-0A2A
Other languages
English (en)
Inventor
Hyo Joon Kim
Heejong Lee
Original Assignee
Sj Biomed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sj Biomed Inc filed Critical Sj Biomed Inc
Publication of BRPI0717223A2 publication Critical patent/BRPI0717223A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
BRPI0717223-0A2A 2006-09-25 2007-09-21 polipeptÍdeos hÍbridos imunogÊnicos antiobesidade e composiÇço de vacina antiobesidade compreendendo os mesmos BRPI0717223A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20060093130 2006-09-25
PCT/KR2007/004692 WO2008038990A1 (en) 2006-09-25 2007-09-21 Anti-obese immunogenic hybrid polypeptides and anti-obese vaccine composition comprising the same

Publications (1)

Publication Number Publication Date
BRPI0717223A2 true BRPI0717223A2 (pt) 2013-09-24

Family

ID=39230370

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0717223-0A2A BRPI0717223A2 (pt) 2006-09-25 2007-09-21 polipeptÍdeos hÍbridos imunogÊnicos antiobesidade e composiÇço de vacina antiobesidade compreendendo os mesmos

Country Status (11)

Country Link
US (1) US20110002955A1 (pt)
EP (1) EP2076544A4 (pt)
JP (1) JP2010504094A (pt)
KR (2) KR100956893B1 (pt)
CN (1) CN101516915A (pt)
AU (1) AU2007300842B2 (pt)
BR (1) BRPI0717223A2 (pt)
CA (1) CA2664529A1 (pt)
MX (1) MX2009003188A (pt)
RU (1) RU2418005C2 (pt)
WO (1) WO2008038990A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101476383B1 (ko) * 2011-07-12 2014-12-24 한국생명공학연구원 단백질 분비융합인자를 포함하는 재조합 벡터 및 이를 이용한 비만백신 단백질의 대량생산 방법
JP2019527192A (ja) 2016-05-31 2019-09-26 カーディオバックス リミテッド ライアビリティ カンパニー 全身性エリテマトーデスの診断及び治療方法
US10858422B2 (en) 2016-05-31 2020-12-08 Abcentra, Llc Methods for treating systemic lupus erythematosus with an anti-apolipoprotein B antibody
KR102261457B1 (ko) * 2020-07-22 2021-06-09 (주)쓰리에이치바이오 면역 치료제용 펩타이드
EP4368638A3 (en) * 2020-07-22 2024-07-31 3H Bio. Co., Ltd. Peptide for immunotherapeutic agent
WO2024040025A2 (en) * 2022-08-19 2024-02-22 University Of Washington Th2 vaccine-based prevention and treatment of inflammation in obesity

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60193926A (ja) 1984-03-15 1985-10-02 Tokyo Daigaku 単クローン性抗ヒトアポリポ蛋白質ｂ１００抗体
US5837249A (en) * 1985-04-19 1998-11-17 The Wistar Institute Method for generating an immunogenic T cell response protective against a virus
US5693325A (en) * 1994-03-15 1997-12-02 Molecumetics, Ltd. Peptide vaccines and methods relating thereto
KR0135708B1 (ko) * 1994-05-31 1998-04-23 김은영 인간 혈중 아포지단백질 비-100(b-100)에 대한 신규 단일클론 항체 및 이들의 생산을 위한 재조합 하이브리도마 세포주
GB0121171D0 (en) 2001-08-31 2001-10-24 Glaxosmithkline Biolog Sa Vaccine
KR100472841B1 (ko) 2000-09-04 2005-03-07 (주)에스제이바이오메드 아포지단백질 비-100의 에피토프에 대한 모조 펩타이드,그들의 연쇄물 또는 변형체와 이들을 함유하는 백신 조성물
CN1231262C (zh) * 2000-09-04 2005-12-14 金晓骏 载脂蛋白b－100表位的模拟肽、其多联体和修饰肽,以及含有这些肽的疫苗组合物
US7241861B2 (en) * 2001-05-15 2007-07-10 Japan Immunoresearch Laboratories Co., Ltd. High density lipoprotein-reactive peptides
CA2496409A1 (en) * 2002-08-30 2004-03-11 Glaxo Group Limited Immunogenic composition comprising an il-13 element and t cell epitopes, and its therapeutic use
AU2004263303A1 (en) * 2003-08-07 2005-02-17 F. Hoffmann-La Roche Ag RA antigenic peptides
KR100639397B1 (ko) * 2004-03-18 2006-10-26 (주)에스제이바이오메드 항비만용 면역원성 하이브리드 폴리펩타이드 및 이를포함하는 항비만 백신 조성물

Also Published As

Publication number Publication date
AU2007300842B2 (en) 2011-01-27
CN101516915A (zh) 2009-08-26
JP2010504094A (ja) 2010-02-12
KR100970178B1 (ko) 2010-07-14
KR20100033395A (ko) 2010-03-29
KR20080027753A (ko) 2008-03-28
RU2009115688A (ru) 2010-11-10
US20110002955A1 (en) 2011-01-06
MX2009003188A (es) 2009-05-22
EP2076544A4 (en) 2009-11-11
CA2664529A1 (en) 2008-04-03
AU2007300842A1 (en) 2008-04-03
KR100956893B1 (ko) 2010-05-11
RU2418005C2 (ru) 2011-05-10
WO2008038990A1 (en) 2008-04-03
EP2076544A1 (en) 2009-07-08

Similar Documents

Publication Publication Date Title
FR22C1008I2 (fr) Composition immunogène
BRPI0914782A2 (pt) peptídeos de epítopos de cdca1 e vacinas contendo os mesmos
IL197094A0 (en) Immunogenic pcpa polypeptides and uses thereof
DK2068918T4 (da) Vaccinesammensætning omfattende syntetisk adjuvant
BRPI0814594A2 (pt) Composições e métodos adjuvantes de antígeno
BRPI0811021A2 (pt) Peptídeos e vacinas de tem8 compreendendo os mesmos
DE602007003596D1 (de) Impfstoff
DK2481420T3 (da) Enkeltdosis-anti-PCV2-svinevaccine
EP2089053A4 (en) VACCINE COMPOSITIONS BASED ON HPV ANTIGEN FUSION PROTEIN AND USES THEREOF
BRPI0813955A2 (pt) composições terapêuticas e o uso das mesmas
BRPI1008887A2 (pt) peptídeos de foxm1 e vacinas contendo os mesmo
ZA201000806B (en) Immunogenic streptococcus proteins
BRPI0917391A2 (pt) peptídeo de epítodo de hig2 e urlc10 e vacinas contendo o mesmo
BRPI1009301A2 (pt) peptídeos neil 3 e vacinas incluindo os mesmos
BRPI0915527A2 (pt) pepitídeos, composição farmacêutica e exossomos compreendendo os mesmos, métodos e usos
IL209870A0 (en) Mybl2 epitope peptides and vaccines containing the same
GB2458080B (en) Sterols modified by polyethylene glycol, the preparation and the use thereof
BRPI0717223A2 (pt) polipeptÍdeos hÍbridos imunogÊnicos antiobesidade e composiÇço de vacina antiobesidade compreendendo os mesmos
BRPI0910570A2 (pt) uso de bioconjugados, e, formulações farmacêuticas
BRPI0909096A2 (pt) uso de conjugados de interleicna-1 no tratamento de diabetes
ATE490782T1 (de) Chimäre vakzine-antigene gegen das klassische schweinefieber-virus
BRPI0919766A2 (pt) peptídeo de epítopo de rab6kifl/kif20a e vacinas contendo o mesmo
BRPI1010666A2 (pt) peptídeos de cdc45l e vacinas incluindo dos mesmos
BRPI1013938A2 (pt) "peptídeos ttk e vacinas incluindo os mesmos"
GB0818065D0 (en) Immunogenic peptides and uses thereof

Legal Events

Date Code Title Description
B08L Patent application lapsed because of non payment of annual fee [chapter 8.12 patent gazette]

Free format text: REFERENTE AO NAO RECOLHIMENTO DAS 6A E 7A ANUIDADES.

B08I Publication cancelled [chapter 8.9 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 8.12 NA RPI NO 2277 DE 26/08/2014 POR TER SIDO INDEVIDA.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 6A, 7A, 8A, 9A, 10A, 11A, 12A E 13A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2602 DE 17-11-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.